[go: up one dir, main page]

AU9655698A - Synthetic genes with immunomodulatory effects - Google Patents

Synthetic genes with immunomodulatory effects

Info

Publication number
AU9655698A
AU9655698A AU96556/98A AU9655698A AU9655698A AU 9655698 A AU9655698 A AU 9655698A AU 96556/98 A AU96556/98 A AU 96556/98A AU 9655698 A AU9655698 A AU 9655698A AU 9655698 A AU9655698 A AU 9655698A
Authority
AU
Australia
Prior art keywords
synthetic genes
immunomodulatory effects
immunomodulatory
effects
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96556/98A
Inventor
Hakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Sarnstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU9655698A publication Critical patent/AU9655698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU96556/98A 1997-10-10 1998-10-06 Synthetic genes with immunomodulatory effects Abandoned AU9655698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94902497A 1997-10-10 1997-10-10
US08949024 1997-10-10
PCT/SE1998/001801 WO1999019347A1 (en) 1997-10-10 1998-10-06 Synthetic genes with immunomodulatory effects

Publications (1)

Publication Number Publication Date
AU9655698A true AU9655698A (en) 1999-05-03

Family

ID=25488491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96556/98A Abandoned AU9655698A (en) 1997-10-10 1998-10-06 Synthetic genes with immunomodulatory effects

Country Status (2)

Country Link
AU (1) AU9655698A (en)
WO (1) WO1999019347A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448348C (en) * 2001-05-25 2013-07-16 Nymox Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
GB0524884D0 (en) * 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
CN115636870B (en) * 2022-11-24 2024-04-30 安徽农业大学 Cyclic color-threo-valyl-leucinyl peptide with hepatoma cytotoxicity and alpha-glucosidase inhibitory activity and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
SE9403526D0 (en) * 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (en) * 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
SE9603463D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds

Also Published As

Publication number Publication date
WO1999019347A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU3491897A (en) Vaccines comprising synthetic genes
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU2124697A (en) Synthetic hiv genes
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU3380897A (en) Synthetic hepatitis c genes
AU9513298A (en) Fluoranthenopyrans
AU8836798A (en) Synthetic termination
AU5272198A (en) EMP-charge-eliminator
AU5166296A (en) New peptides with immunomodulatory effects
AU6998698A (en) Dioxacycloalkan-8-one
AU4117497A (en) Micropolarimeter
AU9655698A (en) Synthetic genes with immunomodulatory effects
AU6417799A (en) Matrix-remodeling genes
AU6185898A (en) Clavaspirins
AU6525998A (en) Improved metallo-endopeptidases
AU8214598A (en) 3-benzylpiperidine
AU6847598A (en) Colour legalisation
AU7761998A (en) Korrosionsschutzanstrichstoff
AU1440097A (en) Ferromagnetic pigments
AU8991998A (en) Renovative pipeliner
AU4469997A (en) Heregulin-gamma
AU5391798A (en) Thiamacrolides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase